1. Miller A, Brown LK. Comments on “COPDGene 2019: redefining the diagnosis of chronic obstructive pulmonary disease.” Chronic Obstr Pulm Dis. 2020;7(2):79-81. doi: https://doi.org/10.15326/jcopdf.7.2.2020.0134
2. Lowe KE, Regan EA, Anzueto A, et al. COPDGene 2019: redefining the diagnosis of chronic obstructive pulmonary disease. Chronic Obstr Pulm Dis. 2019;6(5):384-399. doi: http://doi.org/10.15326/jcopdf.6.5.2019.0149
3. Vogelmeier CF, Criner GJ, Martinez FJ, et al. Global strategy for the diagnosis, management, and prevention of chronic obstructive lung disease 2017 Report. GOLD Executive Summary. Am J Respir Crit Care Med. 2017;195(5):557-582. doi: https://doi.org/10.1164/rccm.201701-0218pp
4. Young KA, Strand MJ, Ragland MF, et al for the COPDGene® Investigators. Pulmonary subtypes exhibit differential Global Initiative for Chronic Obstructive Lung Disease spirometry stage progression: the COPDGene study. Chronic Obstr Pulm Dis. 2019;6(5):414-429. doi: https://doi.org/10.15326/jcopdf.6.5.2019.0155
5. Kinney GL, Santorico SA, Young KA, et al. Identification of chronic obstructive pulmonary disease axes that predict allcause mortality: the COPDGene study. Am J Epidemiol. 2018; 187(10):2109-2116. doi: https://doi.org/10.1093/aje/kwy087
6. Young KA, Regan EA, Han MK, et al and the COPDGene Investigators. Subtypes of COPD have unique distributions and differential risk of mortality. Chronic Obstr Pulm Dis. 2019;6(5):400-413. doi: https://doi.org/10.15326/jcopdf.6.5.2019.0150